Posted by Michael Wonder on 10 Oct 2018
Cure for cancer would become more likely if FDA streamlined the drug approval process
10 October 2018 - The Biden Cancer Initiative recently hosted a meeting in Washington, D.C., pursuant to former vice president Joe Biden’s campaign to create a better cancer research and care system.
As the conference came to a close, I marked the 10th anniversary of my youngest brother’s death from cancer, which came only the month after his first grandchild was born.
Biden’s fight is certainly our fight. However, to win we need to focus not only on innovative research but also on the institutional problems of the FDA. Along with our president at The Heartland Institute and former Republican Tim Huelskamp, we have undertaken a major project to reform the current twentieth century-era FDA system that slows delivery and adds to the costs of the treatments cancer sufferers desperately require. We welcome the chance to work together with Biden to create an innovative drug approval process more responsive to patient needs.
